In a 141-eye series, Aspire and Aspire Toric produced good distance and intermediate results, but no control group allowed comparison with a standard monofocal IOL.
doi: 10.1007/s40123-026-01473-3In a single-center trial, Clareon T2 reduced residual cylinder and improved uncorrected vision, but did not change contrast performance at three months.
doi: 10.3389/fopht.2026.1755069In a retrospective 70-eye comparison, residual astigmatism was 0.13 D lower with femtosecond capsular marking, but treatment groups were not randomized.
doi: 10.4103/IJO.IJO_3062_25In a 2,550-eye retrospective multicenter dataset, Moussa had the lowest mean absolute error, but its margin over the closest formulas was measured in hundredths of a diopter.
doi: 10.1097/j.jcrs.0000000000002079In a 47-eye series, flanged intrascleral fixation of the existing bag–IOL complex improved vision, but five eyes required secondary surgery.
doi: 10.1097/j.jcrs.0000000000001923In a small randomized trial, overall visual-function and satisfaction measures did not differ across three trifocal IOLs; one intermediate-vision item was exploratory.
doi: 10.4103/IJO.IJO_2566_25In 85 patients, Vivity provided better uncorrected near and intermediate vision, whereas PureSee produced higher contrast sensitivity and less dysphotopsia.
doi: 10.1111/aos.70076Reoperation for IOL dislocation occurred in 0.08% of eyes; the strongest associations involved posterior capsule rupture, pseudoexfoliation and iris damage.
doi: 10.2147/OPTH.S542807Among 31,663 phacoemulsification procedures, capsule rupture occurred in 0.74%; 83.3% of analyzed eyes maintained BCVA of at least 20/40 at a median 35 months.
doi: 10.1016/j.jcjo.2026.08.011In a retrospective cohort of 179 eyes, Yamane fixation shortened surgery by about 14 minutes but was associated with a higher hazard of IOL redislocation.
doi: 10.1097/IAE.0000000000004961